Xspray Pharma AB (SE0009973563) — research page
SE · se-cm-kg/XSTO/SE0009973563 · as of 2026-11-06
Identity and listing
The issuer is Xspray Pharma AB, listed on Nasdaq Stockholm under ticker SE0009973563, with ISIN SE0009973563 and LEI 549300NGRQCNZ3X4L157. Security type, segment, sector and jurisdiction are not on the record. Listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Xspray Pharma AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0009973563 | source · 2026-11-06 |
| ISIN | SE0009973563 | source · 2026-11-06 |
| LEI | 549300NGRQCNZ3X4L157 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 28 filings across 22 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 9 days, against a Nasdaq Stockholm median of 9.5 days. The latest filing is dated 2026-11-06 and is an Interim report (Q1 and Q3), with a latency of 0 days to the record date of 2026-11-06. The Nasdaq Stockholm median latency is 7.0 days and the median filings per issuer is 30.0. The sector peer median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 28 | 9 | 0 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Xspray Pharma publishes Interim Report for the third quarter 2026 |
| 2026-11-06 | Inside information | Inside information | Xspray resolves on a rights issue of approximately SEK 90 million with an over-allotment issue of approximately SEK 72 million |
| 2026-11-05 | Inside information | Inside information | Xspray Pharma notified that the FDA has commenced an inspection at NerPharMa's manufacturing facility |
| 2026-10-02 | Investor News | Investor News | Xspray Pharma provides regulatory status update for Dasynoc and Nilopki |
| 2026-09-23 | Investor News | Investor News | Xspray Pharma to present CML data supporting differentiation of Dasynoc and Nilopki |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
One research house is named on the issuer's investor-relations page: Redeye.
| research house | analyst | source · read date |
|---|---|---|
| Redeye | Filip Einarsson | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record start date is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0009973563 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://xspraypharma.com/investors/share-information/ (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0009973563 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0009973563"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:bb522bb2c0f05186.